Uncovering early markers of Parkinson's disease pathological progression using proteomics

被引：0
|
作者：
Pressey, S. N.
Murray, C. E.
Heywood, W.
Gentleman, S. M.
Mills, K.
Holton, J. L.
Gandhi, S.
Revesz, T.
机构：
来源：
MOVEMENT DISORDERS | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1035
引用
收藏
页码：S369 / S369
页数：1
相关论文
共 50 条
  • [41] Parkinson's Progression Markers Initiative (PPMI) Online Expands Biomarker Research in Parkinson's Disease (PD)
    Brown, Ethan
    Alonso, David
    Chahine, Lana
    Coffey, Christopher
    Dobkin, Roseanne
    Korell, Monica
    Lorenzo, Ana
    Marras, Connie
    Poewe, Werner
    Sherer, Todd
    Siderowf, Andrew
    Simuni, Tanya
    Tolosa, Eduardo
    Twiggs, Julien Valverde
    Weintraub, Daniel
    Chowdhury, Sohini
    Marek, Kenneth
    Tanner, Caroline
    MOVEMENT DISORDERS, 2022, 37 : S3 - S4
  • [42] Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?
    Kansara, Sagar
    Trivedi, Akash
    Chen, Sheng
    Jankovic, Joseph
    Le, Weidong
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (01) : 197 - 210
  • [43] Disease progression in Parkinson's disease
    Morita, Y.
    Osaki, Y.
    Furushima, T.
    Miyamoto, Y.
    Furuta, K.
    Furuya, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 585 - 585
  • [44] Remote identification of early, sensor-based markers of Parkinson's disease using participants' smartphones: The Parkinson progression marker initiative digital sub-study
    Popp, W.
    Taylor, K.
    Perumal, T.
    Tanner, C.
    Siderowf, A.
    Chahine, L.
    Brown, E.
    Simuni, T.
    Foroud, T.
    Kustermann, T.
    Pagano, G.
    Svoboda, H.
    Lindemann, M.
    Marek, K.
    MOVEMENT DISORDERS, 2022, 37 : S347 - S347
  • [45] Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?
    Sagar Kansara
    Akash Trivedi
    Sheng Chen
    Joseph Jankovic
    Weidong Le
    Journal of Neural Transmission, 2013, 120 : 197 - 210
  • [46] Longitudinal Progression Markers of Parkinson’s Disease: Current View on Structural Imaging
    Jing Yang
    Roxana G. Burciu
    David E. Vaillancourt
    Current Neurology and Neuroscience Reports, 2018, 18
  • [47] Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging
    Yang, Jing
    Burciu, Roxana G.
    Vaillancourt, David E.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (12)
  • [48] Enhanced sensitivity to bradykinesia progression using digital health technologies in early Parkinson's disease
    Czech, M.
    Yang, L.
    Shen, J.
    Badley, D.
    Crouthamel, M.
    Kangarloo, T.
    Dorsey, R.
    Adams, J.
    Cosman, J.
    MOVEMENT DISORDERS, 2023, 38 : S776 - S777
  • [49] ATNPD Framework Using Biofluid Markers Predicts Cognitive Decline in Early Parkinson's Disease
    Cousins, Katheryn A. Q.
    Irwin, David J.
    Tropea, Thomas F.
    Rhodes, Emma
    Phillips, Jeffrey S.
    Chen-Plotkin, Alice S.
    Brumm, Michael C.
    Coffey, Christopher S.
    Kang, Ju Hee
    Simuni, Tanya
    Foroud, Tatiana
    Toga, Arthur W.
    Tanner, Caroline M.
    Kieburtz, Karl
    Mollenhauer, Brit
    Galasko, Douglas R.
    Hutten, Samantha
    Weintraub, Daniel
    Siderowf, Andrew
    Marek, Kenneth
    Kollmorgen, Gwendlyn
    Poston, Kathleen L.
    Shaw, Leslie M.
    ANNALS OF NEUROLOGY, 2023, 94 : S169 - S169
  • [50] The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease
    Bloem, B. R.
    Marks, W. J., Jr.
    Silva de Lima, A. L.
    Kuijf, M. L.
    van Laar, T.
    Jacobs, B. P. F.
    Verbeek, M. M.
    Helmich, R. C.
    van de Warrenburg, B. P.
    Evers, L. J. W.
    IntHout, J.
    van de Zande, T.
    Snyder, T. M.
    Kapur, R.
    Meinders, M. J.
    BMC NEUROLOGY, 2019, 19 (1)
12345